Skip to main content

CBE Nexus · Bachelor of Science in Biotechnology

Chapter 10: Bioinformatics, Computational Biology and Systems Biotechnology

Biological data, sequence analysis, databases, genomics, transcriptomics, proteomics, modelling, machine learning and reproducible research.

Course catalogue

Home › University Biology › Biotechnology › Chapter 10

Learning outcomes

By the end of this chapter, learners should be able to define and explain its principal concepts, connect biological mechanisms to practical applications, evaluate evidence, identify limitations and discuss safety, ethical and societal considerations. Use your institution's module outline to confirm local learning outcomes and prescribed depth.

Academic and safety note: These notes support independent study. They are not a substitute for approved laboratory manuals, supervision, institutional biosafety procedures, clinical advice or current national regulation. Do not perform biological procedures without appropriate training, authorisation and facilities.

1. Bioinformatics and computational biology

Bioinformatics develops computational methods for storing, retrieving, analysing and interpreting biological data. Computational biology uses mathematical and computational models to investigate biological processes. Systems biotechnology applies these approaches to understand and engineer interactions among genes, proteins, metabolites, cells and environments.

The disciplines overlap but are not identical. A database search may identify sequence similarity; a statistical model may estimate expression differences; a mechanistic simulation may predict pathway behaviour. Each output answers a different question and depends on assumptions, data quality and validation. Computational results should be interpreted as evidence with uncertainty, not as automatic biological truth.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

2. Biological data types and provenance

Biological datasets include DNA and RNA sequences, expression matrices, protein structures, mass-spectrometry measurements, microscopy images, phenotypes, clinical records and environmental observations. Data may be generated by different platforms and protocols, producing batch effects and systematic differences. Metadata describing sample source, processing, instrument, units and experimental design are necessary for meaningful reuse.

Data provenance records where data originated and how they were transformed. A reproducible analysis should preserve raw data where permitted, document quality control, record software and versions, and explain filtering decisions. Human genomic and health data require privacy safeguards, access controls and governance because apparently anonymous records may sometimes be re-identified.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

3. Sequence databases and similarity searching

Sequence databases provide curated or submitted nucleotide and protein records with identifiers and annotations. Similarity-search tools compare a query sequence against a database to identify related sequences. A high-scoring match can suggest homology or shared domains, but interpretation depends on alignment coverage, sequence composition, database quality and evolutionary context.

Similarity is not equivalent to functional identity. Closely related sequences can have different roles, while distant homologues can retain a shared function. Annotation should consider conserved domains, motifs, cellular location, expression evidence and experimental literature. Researchers should distinguish computational prediction from experimentally demonstrated function.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

4. Genome assembly and annotation

Genome assembly reconstructs longer sequences from shorter reads or other measurements. Repeats, sequencing errors, heterozygosity, structural variation and contamination complicate assembly. Assembly quality can be assessed using continuity, completeness, consensus accuracy and evidence from independent data sources. No single metric fully describes whether an assembly is suitable for a particular question.

Annotation identifies features such as genes, transcripts, regulatory regions and repetitive elements. Automated pipelines provide scalable predictions, but errors can propagate when annotations are transferred without sufficient evidence. Curated annotation combines computational prediction, comparative evidence and experimental data. Versioning is important because genome references and annotations are updated over time.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

5. Transcriptomics and differential expression

Transcriptomics examines RNA populations to understand gene expression. RNA sequencing can provide broad measurements of transcript abundance and reveal alternative splicing or previously unannotated transcripts. Experimental design should include biological replication, randomisation where appropriate, balanced batches and a clearly defined comparison.

Differential-expression analysis estimates changes while accounting for variability and multiple testing. A statistically significant difference is not necessarily biologically important. Effect size, confidence intervals, gene-set context and independent validation help interpretation. Sample quality, library preparation and batch effects can influence results and must be assessed before drawing conclusions.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

6. Proteomics and metabolomics

Proteomics studies the protein complement of a biological system, while metabolomics measures small molecules that reflect biochemical activity and environmental influence. Mass spectrometry and other analytical platforms generate complex datasets requiring careful preprocessing, feature identification and quality control. Protein abundance does not always track RNA abundance because translation, degradation and post-translational regulation differ.

Metabolite identification can be uncertain when reference spectra or standards are unavailable. Analytical drift, extraction bias and batch effects can create misleading patterns. Integrating proteomic and metabolomic evidence with genomics and transcriptomics can generate stronger hypotheses, but integration must account for different measurement scales, missingness and biological time scales.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

7. Structural bioinformatics and molecular modelling

Structural bioinformatics analyses the three-dimensional structures of proteins, nucleic acids and molecular complexes. Structural information can help explain binding, catalysis, stability and molecular recognition. Experimental structures and computational predictions have different uncertainty profiles, and confidence should be considered at the region and interaction level rather than inferred from a single global score.

Molecular docking and simulation can prioritise hypotheses about interactions, but they do not prove binding or therapeutic efficacy. Results depend on input structures, protonation states, conformational flexibility, solvent models and scoring assumptions. Experimental assays are needed to test important predictions. Responsible reporting makes clear which findings are computational and which are experimentally supported.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

8. Systems biology and network analysis

Systems biology studies interactions among components rather than treating each gene or molecule in isolation. Networks may represent protein interactions, metabolic reactions, regulatory relationships or ecological associations. Network topology can identify highly connected nodes or modules, but centrality measures depend on how the network was constructed and may reflect research bias.

Dynamic models describe how biological variables change over time. Ordinary differential equations, stochastic models and constraint-based metabolic models each capture different aspects of biology. Model selection should match the question and available data. Sensitivity analysis, parameter estimation and independent validation help determine whether predictions are robust.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

9. Machine learning in biotechnology

Machine learning can classify images, predict molecular properties, prioritise candidate sequences and analyse high-dimensional biological data. Supervised learning uses labelled examples, unsupervised learning identifies structure without predefined labels, and reinforcement learning optimises actions through feedback. Model performance depends on data representativeness, label quality and the intended deployment setting.

Data leakage occurs when information from the test set influences training or model selection, producing overly optimistic performance. Proper separation of training, validation and test data is essential. External validation is especially important when models are applied to new laboratories, populations, species or instruments. Accuracy alone may be inadequate where false negatives and false positives have different consequences.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

10. Reproducibility, ethics and responsible data science

Reproducible computational research uses documented workflows, versioned code, environment specifications, clear data dictionaries and transparent reporting. Not all data can be openly shared, especially where human privacy, commercial confidentiality or Indigenous data governance applies. Controlled access and clear consent can support responsible reuse without ignoring legitimate restrictions.

Bias can enter through sampling, measurement, annotation and model design. A model trained on unrepresentative data may perform poorly for underrepresented populations or environments. Researchers should report limitations, uncertainty and intended use, and avoid overstating predictive performance. Human oversight remains necessary when computational outputs influence clinical, agricultural or environmental decisions.

Critical study point: Explain the biological principle in your own words, identify the evidence needed to support a conclusion, and state at least one limitation or source of uncertainty. Connect the concept to an authentic application without assuming that laboratory feasibility guarantees real-world benefit.

Conceptual workflow
Define problem→Choose biological system→Design and test→Validate evidence→Evaluate impact
Evidence and quality cycle
Sample / material→Measurement→Quality control→Analysis→Independent confirmation
Responsible innovation framework
Scientific merit+Safety+Ethics+Equity+Monitoring

Applied case study

A research or production team is considering a biotechnology intervention to address a defined challenge. Before implementation, the team must establish the baseline problem, identify the biological mechanism, compare alternative approaches and define measurable success criteria. It should assess technical feasibility, resource requirements, quality controls, potential hazards and the distribution of benefits and risks.

The team develops a study plan with appropriate controls and independent measurements. Results are analysed against predefined endpoints, including uncertainty and unexpected observations. The team then considers whether evidence supports further development, whether additional validation is required or whether the approach should be revised or discontinued. This decision-based approach prevents attractive preliminary findings from being mistaken for proof of practical effectiveness.

Practical learning activity: design an evidence plan

  1. Write a focused research question relevant to this chapter.
  2. State a testable hypothesis and identify the independent and dependent variables.
  3. Identify positive, negative and process controls where appropriate.
  4. Specify the sample type, measurement method and quality checks.
  5. Explain how results would be analysed and independently validated.
  6. Identify biosafety, ethics, environmental and data-governance requirements.
  7. Present a short report distinguishing observations, interpretation and limitations.

Assessment rubric: Scientific accuracy (25%); study design and controls (25%); interpretation and limitations (20%); safety and ethics (15%); clarity, referencing and reproducibility (15%).

Revision and examination questions

  1. 1. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  2. 2. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  3. 3. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  4. 4. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  5. 5. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  6. 6. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  7. 7. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  8. 8. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  9. 9. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  10. 10. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  11. 11. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  12. 12. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  13. 13. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  14. 14. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

  15. 15. Explain a central principle from this chapter and show how it informs a biotechnology application. In your answer, define key terms, describe the evidence required and discuss one limitation.

    Marking guidance: Award credit for accurate terminology, a logical explanation, relevant application, appropriate evidence and critical evaluation.

Revision checklist

Further study: Consult current undergraduate biotechnology textbooks, peer-reviewed reviews, primary research and guidance from relevant scientific and regulatory bodies. Verify that sources are current and applicable to your jurisdiction.

← Return to Biotechnology course catalogue

Official Education References

Use these official organisations for curriculum guidance, examinations and further learning information.